Ten years survival outcome of breast cancer patients among South Indian population: A retrospective cohort study

نویسندگان
doi
10.48309/jmpcr.2025.485231.1479
چکیده

In India, breast cancer is the most frequently diagnosed malignancy in women; however, there is a lack of research on long-term survival rates. Long-term oncological outcomes in curable breast cancer patients were examined in this study. This study presents a retrospective cohort analysis of 250 patients with various stages of breast cancer who received curative primary treatment at a cancer facility in South India between 2013 and 2023.  Final analysis included 250 breast cancer patients, with a median age of 51 years (range: 21 to 69 years). 84.8% of patients presented with early breast cancer disease (EBC), 15.2% exhibited locally advanced breast cancer disease (LABC), and 28% had newly developed metastatic disease which requires surgical treatment. 53.6% of patients presented with hormone-sensitive tumors, 28% exhibited overexpression of the human epidermal growth factor-2 receptor (HER-2), and 55% were diagnosed with triple-negative breast cancer tumors (TNBC).  After initial cancer treatment, the cohort had overall survival (OS) rates of 95% at 5 years and 50% at 10-years. EBC and LABC were associated with extended survival in multivariate analysis. Early-stage disease and subsequent primary cancer treatment has better 10-year survival rates.